Bridge to Life
PrivateLast Round
Series C
Aug 12, 2026
Est. Valuation
$470M
Total Funding Raised
$237M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Bridge to Life is a biotechnology company that develops and markets innovative organ preservation and machine perfusion technologies to improve transplant outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bridge to Life Comparables
Compare Bridge to Life with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Getinge AB | 86% | |
| Shanghai Genext Medical Technology Co., Ltd. | 82% | |
| Xvivo Perfusion | 81% | |
Bridge to Life Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 12, 2026 | ||||
| Series A Extension | Aug 28, 2024 | ||||
| Strategic | Aug 2, 2023 | ||||
| Debt | Aug 19, 2021 | ||||
| VC Round | Jan 21, 2009 |
Key People
Founding team and executive leadership
Bridge to Life Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Soleus Capital | Series C |
| Perceptive Advisors | Debt |
| Lauxera Capital Partners | Series C |
| Wisconsin Alumni Research Foundation | VC Round |
| SCRA | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 12, 2026
$110M round led by Soleus Capital
- Mar 24, 2026
VitaSmart HOPE System received FDA clearance for US commercial use.
Bridge to Life Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bridge to Life's valuation, stock price, and market status.